Polymyalgia Rheumatica and Giant Cell Arteritis

被引:37
作者
Buttgereit, Frank [1 ]
Matteson, Eric L. [2 ]
Dejaco, Christian [3 ,4 ]
机构
[1] Charite, Dept Rheumatol & Clin Immunol, Charitepl 1, D-10117 Berlin, Germany
[2] Mayo Clin, Coll Med & Sci, Div Rheumatol, Rochester, MN USA
[3] Med Univ Graz, Dept Rheumatol & Immunol, Graz, Austria
[4] Hosp Brunico SABES ASDAA, Dept Rheumatol, Brunico, Italy
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2020年 / 324卷 / 10期
关键词
DOUBLE-BLIND; TOCILIZUMAB; TRIAL;
D O I
10.1001/jama.2020.10155
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This JAMA Insights Clinical Update reviews the diagnosis and management of polymyalgia rheumatica and giant cell arteritis and provides a suggested treatment algorithm for giant cell arteritis.
引用
收藏
页码:993 / 994
页数:2
相关论文
共 50 条
  • [41] Treatment with Glucocorticoids for Polymyalgia Rheumatica and Giant-Cell Arteriitis
    Fiehn, C.
    AKTUELLE RHEUMATOLOGIE, 2014, 39 (04) : 252 - 255
  • [42] Association between glucocorticoid therapy and incidence of diabetes mellitus in polymyalgia rheumatica and giant cell arteritis: a systematic review and meta-analysis
    Lai, Lana Yin Hui
    Harris, Emma
    West, Robert M.
    Mackie, Sarah Louise
    RMD OPEN, 2018, 4 (01):
  • [43] Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database
    Albrecht, Katinka
    Huscher, Doerte
    Buttgereit, Frank
    Aringer, Martin
    Hoese, Guido
    Ochs, Wolfgang
    Thiele, Katja
    Zink, Angela
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (04) : 569 - 577
  • [44] The DANIsh VASculitis cohort study: protocol for a national multicenter prospective study including incident and prevalent patients with giant cell arteritis and polymyalgia rheumatica
    Nielsen, Berit D.
    Kristensen, Salome
    Donskov, Agnete
    Terslev, Lene
    Dreyer, Lene Wohlfahrt
    Colic, Ada
    Hetland, Merete Lund
    Hojgaard, Pil
    Ellingsen, Torkell
    Hauge, Ellen-Margrethe
    Chrysidis, Stavros
    Keller, Kresten K.
    FRONTIERS IN MEDICINE, 2024, 11
  • [45] Treatment of polymyalgia rheumatica
    Castaneda, Santos
    Garcia-Castaneda, Noelia
    Prieto-Pena, Diana
    Martinez-Quintanilla, Dolores
    Vicente, Esther F.
    Blanco, Ricardo
    Gonzalez-Gay, Miguel A.
    BIOCHEMICAL PHARMACOLOGY, 2019, 165 : 221 - 229
  • [46] Ophthalmic manifestations of giant cell arteritis
    Wong, Calvin W.
    Alryalat, Saif Aldeen
    Al Deyabat, Osama
    Lee, Andrew G.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2024, 19 (02) : 133 - 140
  • [47] Current advances in giant cell arteritis
    Kaushik, Megha
    Ponte, Cristina
    Mollan, Susan P.
    CURRENT OPINION IN NEUROLOGY, 2021, 34 (01) : 133 - 141
  • [48] Updates in the Management of Giant Cell Arteritis
    Baig, Aqil
    Gafoor-Haseeb, Sana
    Goldsher, Jay
    Siddique, Faizah
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2024, 24 (08) : 285 - 291
  • [49] Ustekinumab for the Treatment of Giant Cell Arteritis
    Matza, Mark A.
    Fernandes, Ana D.
    Stone, John H.
    Unizony, Sebastian H.
    ARTHRITIS CARE & RESEARCH, 2021, 73 (06) : 893 - 897
  • [50] Polymyalgia rheumatica
    Espigol-Frigole, Georgina
    Dejaco, Christian
    Mackie, Sarah L.
    Salvarani, Carlo
    Matteson, Eric L.
    Cid, Maria C.
    LANCET, 2023, 402 (10411) : 1459 - 1472